Measured Wealth Private Client Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$815K Sell
3,336
-22
-0.7% -$5.12K 0.22% 69
2025
Q4
$695K Sell
3,358
-13
-0.4% -$2.57K 0.18% 73
2025
Q3
$625K Sell
3,371
-150
-4% -$25.7K 0.17% 80
2025
Q2
$538K Buy
3,521
+157
+5% +$24.1K 0.16% 93
2025
Q1
$558K Sell
3,364
-93
-3% -$14.6K 0.18% 79
2024
Q4
$500K Sell
3,457
-19
-0.5% -$2.94K 0.16% 84
2024
Q3
$563K Sell
3,476
-1,385
-28% -$221K 0.19% 70
2024
Q2
$710K Sell
4,861
-187
-4% -$27.8K 0.25% 63
2024
Q1
$799K Hold
5,048
0.28% 56
2023
Q4
$791K Sell
5,048
-348
-6% -$53.4K 0.29% 50
2023
Q3
$840K Buy
5,396
+48
+0.9% +$7.92K 0.34% 44
2023
Q2
$885K Buy
5,348
+78
+1% +$12.6K 0.34% 39
2023
Q1
$817K Sell
5,270
-152
-3% -$24.5K 0.31% 43
2022
Q4
$958K Buy
5,422
+100
+2% +$17.3K 0.39% 36
2022
Q3
$869K Sell
5,322
-181
-3% -$30.6K 0.38% 38
2022
Q2
$977K Sell
5,503
-160
-3% -$28.5K 0.43% 37
2022
Q1
$1M Sell
5,663
-547
-9% -$93.1K 0.37% 35
2021
Q4
$1.06M Sell
6,210
-89
-1% -$14.6K 0.38% 41
2021
Q3
$1.02M Sell
6,299
-1,491
-19% -$254K 0.39% 40
2021
Q2
$1.28M Buy
7,790
+652
+9% +$108K 0.41% 44
2021
Q1
$1.17M Sell
7,138
-1,750
-20% -$283K 0.42% 41
2020
Q4
$1.4M Sell
8,888
-645
-7% -$95.2K 0.58% 32
2020
Q3
$1.42M Buy
9,533
+1,082
+13% +$160K 0.69% 23
2020
Q2
$1.19M Buy
8,451
+2,530
+43% +$369K 0.69% 23
2020
Q1
$776K Sell
5,921
-244
-4% -$34.6K 0.6% 26
2019
Q4
$899K Sell
6,165
-505
-8% -$68.5K 0.6% 24
2019
Q3
$863K Sell
6,670
-2,342
-26% -$309K 0.56% 30
2019
Q2
$1.25M Sell
9,012
-1,001
-10% -$139K 0.72% 27
2019
Q1
$1.4M Sell
10,013
-189
-2% -$25.3K 0.86% 20
2018
Q4
$1.32M Sell
10,202
-741
-7% -$103K 1.19% 18
2018
Q3
$1.51M Buy
10,943
+258
+2% +$34.3K 0.91% 15
2018
Q2
$1.29M Buy
+10,685
New +$1.33M 1.05% 16
2017
Q3
$855K Buy
+6,580
New +$872K 1.17% 22

Other funds holding JNJ

Measured Wealth Private Client Group's JNJ Position: Q1 2026 in Review

Measured Wealth Private Client Group reduced its Johnson & Johnson (JNJ) stake by 0.66% in Q1 2026, selling an estimated $5.12K and leaving 3,336 shares worth $815K. The position accounts for 0.22% of the portfolio, ranked #69.

Measured Wealth Private Client Group first reported a position in JNJ in Q3 2017 and has held it in 33 quarters since. The position peaked at $1.51M in Q3 2018. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Measured Wealth Private Client Group held 3,336 shares of Johnson & Johnson worth $815K as of Q1 2026.
  • Measured Wealth Private Client Group sold 22 Johnson & Johnson shares in Q1 2026, an estimated $5.12K.
  • Johnson & Johnson made up 0.22% of Measured Wealth Private Client Group's portfolio in Q1 2026, its #69 holding.
  • Measured Wealth Private Client Group first reported a position in Johnson & Johnson in Q3 2017 and has held it in 33 quarters since.
  • Measured Wealth Private Client Group's Johnson & Johnson position peaked at $1.51M in Q3 2018.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q1 2026, filed 13 May 2026.